Literature DB >> 9010227

Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs.

T Zarkowska1, S U, E Harlow, S Mittnacht.   

Abstract

The growth suppressive activity of the retinoblastoma tumour suppressor protein is controlled by cell cycle dependent phosphorylation. However, while many in vivo phosphorylation sites have been mapped, the identities of those residues whose phosphorylation is regulated remain elusive. We have mapped the epitopes of three independent monoclonal antibodies that recognise a distinction between differentially phosphorylated pRB sub-populations. All three antibodies recognise an identical epitope which encompasses an essential serine positioned within a consensus site for proline directed kinase phosphorylation. We provide evidence that this residue, serine 608 of pRB, is an authentic phosphorylation site that can be phosphorylated in vitro by cyclin A-CDK2 and cyclin D1-CDK4 kinases but not by cyclin E-CDK2 kinase or the mitogen activated kinase ERK2. Phosphorylation at this residue seems to be cell cycle regulated, occurring prior to entry into the S phase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010227     DOI: 10.1038/sj.onc.1200824

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation.

Authors:  Feng Bai; Ho Lam Chan; Matthew D Smith; Hiroaki Kiyokawa; Xin-Hai Pei
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

3.  Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

Authors:  A S Lundberg; R A Weinberg
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

4.  Rb binds c-Jun and activates transcription.

Authors:  M A Nead; L A Baglia; M J Antinore; J W Ludlow; D J McCance
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

5.  Limited redundancy in phosphorylation of retinoblastoma tumor suppressor protein by cyclin-dependent kinases in acute lymphoblastic leukemia.

Authors:  Nicole M R Schmitz; Andreas Hirt; Markus Aebi; Kurt Leibundgut
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.

Authors:  Feng Bai; Xin-Hai Pei; Toru Nishikawa; Matthew D Smith; Yue Xiong
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

7.  The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1.

Authors:  D Godden-Kent; S J Talbot; C Boshoff; Y Chang; P Moore; R A Weiss; S Mittnacht
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  RB activation defect in tumor cell lines.

Authors:  Cristina Broceño; Scott Wilkie; Sibylle Mittnacht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-11       Impact factor: 11.205

Review 9.  The role and regulation of D-type cyclins in the plant cell cycle.

Authors:  M Meijer
Journal:  Plant Mol Biol       Date:  2000-08       Impact factor: 4.076

10.  Inhibition of E2F1 activity and cell cycle progression by arsenic via retinoblastoma protein.

Authors:  Lynn A Sheldon
Journal:  Cell Cycle       Date:  2017-09-28       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.